ARCIELLO, ANGELA
 Distribuzione geografica
Continente #
EU - Europa 3.552
AS - Asia 2.911
NA - Nord America 2.666
SA - Sud America 419
AF - Africa 96
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.647
Nazione #
US - Stati Uniti d'America 2.583
SG - Singapore 1.450
RU - Federazione Russa 1.449
IT - Italia 1.173
CN - Cina 804
BR - Brasile 364
DE - Germania 293
HK - Hong Kong 228
VN - Vietnam 197
FI - Finlandia 131
NL - Olanda 125
FR - Francia 74
IN - India 66
IE - Irlanda 65
GB - Regno Unito 60
CA - Canada 56
CI - Costa d'Avorio 49
UA - Ucraina 40
ZA - Sudafrica 34
KR - Corea 31
SE - Svezia 30
PL - Polonia 28
BD - Bangladesh 27
JP - Giappone 24
MX - Messico 20
AR - Argentina 19
ES - Italia 19
EC - Ecuador 16
AT - Austria 14
IR - Iran 13
CZ - Repubblica Ceca 9
ID - Indonesia 9
IL - Israele 9
IQ - Iraq 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
LT - Lituania 8
PK - Pakistan 8
TR - Turchia 8
BE - Belgio 6
BG - Bulgaria 5
MA - Marocco 5
VE - Venezuela 5
CO - Colombia 4
UZ - Uzbekistan 4
CL - Cile 3
EG - Egitto 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
BN - Brunei Darussalam 2
DK - Danimarca 2
KE - Kenya 2
KG - Kirghizistan 2
NP - Nepal 2
RS - Serbia 2
SA - Arabia Saudita 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DM - Dominica 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.647
Città #
Singapore 686
Chandler 436
Moscow 385
Beijing 275
Naples 267
Ashburn 248
Hong Kong 222
Napoli 184
Santa Clara 146
Hefei 128
Amsterdam 102
Munich 85
Millbury 81
Los Angeles 76
Ho Chi Minh City 57
Nanjing 57
Princeton 50
Boston 48
New York 44
Buffalo 42
Turku 41
Dallas 38
Helsinki 38
Jacksonville 37
Dong Ket 36
Seattle 34
São Paulo 34
Hanoi 33
Falkenstein 30
Frankfurt am Main 30
Des Moines 29
Milan 29
Lawrence 28
Redondo Beach 28
Seoul 25
Rome 24
Hyderabad 23
Ottawa 20
Nuremberg 19
Düsseldorf 18
Phoenix 18
Rio de Janeiro 18
Warsaw 18
Tokyo 17
Brooklyn 16
Chicago 16
Hebei 16
Johannesburg 16
Redwood City 16
Shenyang 16
Chennai 14
Wilmington 14
Woodbridge 14
London 13
Nanchang 13
Tianjin 13
Ann Arbor 12
Stockholm 12
Bari 11
Caserta 11
Guangzhou 11
Lappeenranta 11
Lauterbourg 11
Pune 11
Washington 11
Bacoli 10
Mexico City 10
Montreal 10
Portici 10
San Francisco 10
Toronto 10
Poplar 9
San Giorgio a Cremano 9
Changsha 8
Denver 8
Falls Church 8
Houston 8
Jinan 8
Karlsruhe 8
Norwalk 8
Roubaix 8
Afragola 7
Belo Horizonte 7
Brasília 7
Castellammare Di Stabia 7
Dublin 7
Fairfield 7
Hải Dương 7
Jiaxing 7
Quito 7
Salerno 7
San Diego 7
San Nicola la Strada 7
Succivo 7
Taizhou 7
Torre del Greco 7
Zhengzhou 7
Atlanta 6
Aviano 6
Bắc Ninh 6
Totale 4.834
Nome #
Cryptic antimicrobial peptides, a still unexploited source of bioactive peptides 237
Femtosecond UV-laser pulses to unveil protein-protein interactions in living cells 185
3D GRID-based pharmacophore and Metadynamics approaches for the rational design of N-Methyl β-sheet breaker peptides as inhibitors of the Alzheimer's Aβ-amyloid fibrillogenesis 179
Novel human bioactive peptides identified in Apolipoprotein B: Evaluation of their therapeutic potential 178
Insights into the anticancer properties of the first antimicrobial peptide from Archaea 150
Human Cryptic Host Defence Peptides: identification and analysis of their antimicrobial, anti-biofilm and immunomodulatory properties 148
A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase 1 -like: from in silico identification to experimental evidence 145
Protective Effects of Recombinant Human Angiogenin in Keratinocytes: New Insights on Oxidative Stress Response Mediated by RNases 136
Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variants 135
Edible Films Made of Dried Olive Leaf Extract and Chitosan: Characterization and Applications 130
A powerful in silico approach allowed the identification of a new antimicrobial peptide from the third domain of life 129
Cryptides Identified in Human Apolipoprotein B as New Weapons to Fight Antibiotic Resistance in Cystic Fibrosis Disease 128
Human Cryptic Host Defence Peptide GVF27 Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia cepacia Complex 127
Identification of novel direct protein-protein interactions by irradiating living cells with femtosecond UV laser pulses 125
Fighting multidrug resistance with a fruit extract: anti-cancer and anti-biofilm activities of Acca sellowiana 125
Development and characterization of antimicrobial and antioxidant whey protein-based films functionalized with Pecan (Carya illinoinensis) nut shell extract 122
Cost-effective production of recombinant peptides in Escherichia coli 120
Enzymatically active fibrils generated by self-assembly of the ApoA-I fibrillogenic domain functionalized with a catalytic moiety. 117
Tailoring the stress response of human skin cells by substantially limiting the nuclear localization of angiogenin 115
Novel human antimicrobial peptides from ApoB are endowed with promising anti-inflammatory properties 115
Insights into Carbonic Anhydrase VII functional role 114
Catalytic fibrils, a nanoscale biomaterial generated by amyloid fibrils functionalized with an enzyme 113
Human apolipoprotein E as a reservoir of cryptic bioactive peptides: The case of ApoE 133-167 113
Improved shelf-life of Nabulsi cheese wrapped with hydrocolloid films 113
Synthetic Antibiotic Derived from Sequences Encrypted in a Protein from Human Plasma 113
Insights into the interaction of the N-terminal amyloidogenic polypeptide of ApoA-I with model cellular membranes 112
The 93-residue N-terminal domain of apolipoprotein A-I (ApoA-I), responsible for amyloid formation, is a cytotoxic agent. 111
Biocompatibility, uptake and endocytosis pathways of polystyrene nanoparticles in primary human renal epithelial cells. 111
All natural mussel-inspired bioadhesives from soy proteins and plant derived polyphenols with marked water-resistance and favourable antibacterial profile for wound treatment applications 109
Amyloidoses associated to Apolipoprotein A-I: analysis of the molecular bases of the disease 109
Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids 108
A proteomic approach to investigate the effects of cadmium and lead on human primary renal cells. 107
Development and properties of new chitosan-based films plasticized with spermidine and/or glycerol 106
Host defense peptides identified in human apolipoprotein B as natural food bio-preservatives: Evaluation of their biosafety and digestibility 104
Toxicity and membrane perturbation properties of the ribotoxin-like protein Ageritin 102
Transglutaminase-mediated crosslinking of a host defence peptide derived from human apolipoprotein B and its effect on the peptide antimicrobial activity 101
Environment‐sensitive fluorescent labelling of peptides by luciferin analogues 101
Rapid detection of Candida albicans in urine by an Electrochemical Impedance Spectroscopy (EIS)-based biosensor 101
Effects of human antimicrobial cryptides identified in apolipoprotein B depend on specific features of bacterial strains 100
Immunotoxins and ImmunoRNases 98
Synthesis, biological evaluation and metadynamics simulations of novel N-methyl β-sheet breaker peptides as inhibitors of Alzheimer's β-amyloid fibrillogenesis 97
Apolipoprotein A-I associated amyloidoses: the intriguing case of a natively unfolded protein fragment. 97
Human Antitumor RNases and ImmunoRNases 96
Expression and characterization of recombinant apolipoprotein A-I (ApoA-I) fibrillogenic domain: first steps towards a structural and functional definition of ApoA-I associated amyloidosis 96
Human carbonic anhydrase VII protects cells from oxidative damage 96
Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential 95
Expression of human apolipoprotein A-I in Nicotiana tabacum 95
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis 94
Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-I 94
Cytotoxicity of an innovative pressurised cyclic solid–liquid (Pcsl) extract from artemisia annua 94
Two series of benzofuran and benzodifuran chelating chromophores with DR/NIR emission and anticancer activity 93
Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells. 93
Physicochemical and antimicrobial properties of whey protein-based films functionalized with palestinian Satureja capitata essential oil 93
Nuclear and plastidial expression of the gene encoding human apolipoprotein ApoA.I in tobacco 92
Human Carbonic Anhydrase VII protects cells from oxidative damage 92
Bioactive protein-based films containing an antimicrobial apolipoprotein B fragment. 92
Screen printed based impedimetric immunosensor for rapid detection of Escherichia coli in drinking water 92
Expression of ApoA-I human apolipoprotein mutants in tobacco plants 91
Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by attenuating the protective activity of angiogenin 91
Controlled Pore Glass-based oligonucleotide affinity support: towards High Throughput Screening methods for the identification of conformation-selective G-quadruplex ligands 91
Host Defence Cryptides from Human Apolipoproteins: Applications in Medicinal Chemistry 91
Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10 91
Dna binding mode analysis of a core-extended naphthalene diimide as a conformation-sensitive fluorescent probe of g-quadruplex structures 90
Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity? 89
Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant 88
Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation 88
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 88
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 87
Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance 87
Novel bioactive peptides from PD-L1/2, a type 1 ribosome inactivating protein from Phytolacca dioica L. Evaluation of their antimicrobial properties and anti-biofilm activities 87
A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas. 86
Amyloidoses associated to apolipoprotein A-I: The intriguing case of a natively unfolded protein fragment 86
Human, Anti-ErbB2 Antitumor Immunoagents 85
Binding, internalization and extracellular route of the fibrillogenic fragment of ApoA-I in cardiomyoblasts 85
Host defence peptides identified in human apolipoprotein B as promising antifungal agents 85
Ephedra foeminea as a Novel Source of Antimicrobial and Anti-Biofilm Compounds to Fight Multidrug Resistance Phenotype 84
Loading of Polydimethylsiloxane with a Human ApoB-Derived Antimicrobial Peptide to Prevent Bacterial Infections 83
KNR50: a moonlighting bioactive peptide hidden in the C-terminus of bovine casein αS2 with powerful antimicrobial, antibiofilm, antiviral and immunomodulatory activities 82
IMMUNORNASES AS ANTITUMOUR AGENTS 82
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 81
Fibrillogenesis of ApoA-1 1-93: Identification of an intermediate with a collapsed and partially folded conformation 81
Novel Antimicrobial Strategies to Prevent Biofilm Infections in Catheters after Radical Cystectomy: A Pilot Study 80
Host defense peptides identified in human apolipoprotein B as novel food biopreservatives and active coating components 78
Ribonucleases as Antitumor Agents 75
ImmunoRNases as antitumor agents 75
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 74
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells 74
Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic Peptide of apolipoprotein a-I. 74
Novel Retro-Inverso Peptide Antibiotic Efficiently Released by a Responsive Hydrogel-Based System 72
A DR/NIR Hybrid Polymeric Tool for Functional Bio-Coatings: Theoretical Study, Cytotoxicity, and Antimicrobial Activity 71
Fully Human Anti-Cancer ImmunoAgents 69
Apolipoprotein A-I: the dual face of a protein 67
Inflammation protein quantification by multiple reaction monitoring mass spectrometry in lipopolysaccharide-stimulated THP-1 cells 66
Impact of a single point mutation on the antimicrobial and fibrillogenic properties of cryptides from human apolipoprotein B 64
Antimicrobial and antibiofilm activity of specialized metabolites isolated from Centaurea hyalolepis 60
Effects of disease-associated mutations on the aggregation process of the 93-residue N-terminal fragment of human apolipoprotein A-I 58
When annealing is detrimental: The case of HMGB1-targeting G-quadruplex aptamers 53
Dual-action thioarylamide-based small molecules to target drug-resistant bacteria and chronic inflammation 16
Covalently linked dimers of a G-quadruplex-forming aptamer as HMGB1 inhibitors 15
Enzymatically Crafted Bacterial Cellulose Nanoparticles Functionalized With Antimicrobial Peptides: Toward Sustainable Antimicrobial Formulations 13
Totale 9.826
Categoria #
all - tutte 31.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 33 22 16 40 20 10 63 43
2021/2022618 6 5 7 28 14 7 6 18 121 50 143 213
2022/20231.100 116 127 50 69 113 111 56 94 185 111 56 12
2023/2024721 35 110 62 44 49 92 51 96 18 21 90 53
2024/20253.276 135 87 26 53 114 194 332 211 233 347 1.266 278
2025/20262.926 644 416 595 652 619 0 0 0 0 0 0 0
Totale 9.859